CN1814153A - Medicine composition for preventing and treating breast cancer and preparing method - Google Patents
Medicine composition for preventing and treating breast cancer and preparing method Download PDFInfo
- Publication number
- CN1814153A CN1814153A CN 200510061810 CN200510061810A CN1814153A CN 1814153 A CN1814153 A CN 1814153A CN 200510061810 CN200510061810 CN 200510061810 CN 200510061810 A CN200510061810 A CN 200510061810A CN 1814153 A CN1814153 A CN 1814153A
- Authority
- CN
- China
- Prior art keywords
- radix
- standby
- ethanol
- add
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010006187 Breast cancer Diseases 0.000 title claims abstract description 26
- 208000026310 Breast neoplasm Diseases 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract 7
- 239000003814 drug Substances 0.000 title claims description 19
- 229940079593 drug Drugs 0.000 title claims description 4
- 239000000203 mixture Substances 0.000 title claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000009636 Huang Qi Substances 0.000 claims abstract description 18
- 239000010135 fructus aurantii immaturus Substances 0.000 claims abstract description 18
- 239000002775 capsule Substances 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- 238000010992 reflux Methods 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 238000005303 weighing Methods 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 23
- 201000008275 breast carcinoma Diseases 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 16
- 239000003826 tablet Substances 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 8
- 230000002265 prevention Effects 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 235000008504 concentrate Nutrition 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 238000012869 ethanol precipitation Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims 1
- 239000000890 drug combination Substances 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 238000005457 optimization Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000001476 alcoholic effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 3
- 244000020518 Carthamus tinctorius Species 0.000 abstract 3
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 3
- 240000001949 Taraxacum officinale Species 0.000 abstract 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 3
- 244000025361 Ficus carica Species 0.000 abstract 2
- 235000008730 Ficus carica Nutrition 0.000 abstract 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 238000012216 screening Methods 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000013049 sediment Substances 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 4
- 208000030270 breast disease Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000002445 nipple Anatomy 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 206010006223 Breast discharge Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000004686 stellate ganglion Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Group | The example number | Produce effects (%) | Effectively (%) | Invalid (%) |
Treatment group matched group | 100 100 | 28(28) 11(11) | 68(68) 15(15) | 4(4) 74(74) |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510061810 CN1814153B (en) | 2005-12-05 | 2005-12-05 | Medicine composition for preventing and treating breast cancer and preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510061810 CN1814153B (en) | 2005-12-05 | 2005-12-05 | Medicine composition for preventing and treating breast cancer and preparing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1814153A true CN1814153A (en) | 2006-08-09 |
CN1814153B CN1814153B (en) | 2011-09-07 |
Family
ID=36906585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510061810 Expired - Fee Related CN1814153B (en) | 2005-12-05 | 2005-12-05 | Medicine composition for preventing and treating breast cancer and preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1814153B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102018736A (en) * | 2010-11-19 | 2011-04-20 | 成都中医药大学 | Natural indigo decoction piece and preparation method thereof |
CN102273726A (en) * | 2010-06-08 | 2011-12-14 | 湖北中烟工业有限责任公司 | Preparation method of fig fermentation extract and application thereof to reconstituted tobacco |
CN108567893A (en) * | 2017-03-08 | 2018-09-25 | 洛阳士雄聚元医疗集团股份有限公司 | It is a kind of to treat carcinoid oral traditional Chinese medicine composition |
-
2005
- 2005-12-05 CN CN 200510061810 patent/CN1814153B/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102273726A (en) * | 2010-06-08 | 2011-12-14 | 湖北中烟工业有限责任公司 | Preparation method of fig fermentation extract and application thereof to reconstituted tobacco |
CN102018736A (en) * | 2010-11-19 | 2011-04-20 | 成都中医药大学 | Natural indigo decoction piece and preparation method thereof |
CN102018736B (en) * | 2010-11-19 | 2012-03-28 | 成都中医药大学 | Natural indigo decoction piece and preparation method thereof |
CN108567893A (en) * | 2017-03-08 | 2018-09-25 | 洛阳士雄聚元医疗集团股份有限公司 | It is a kind of to treat carcinoid oral traditional Chinese medicine composition |
Also Published As
Publication number | Publication date |
---|---|
CN1814153B (en) | 2011-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101085223A (en) | Medicine for treating rheumatism and rheumatoid disease | |
WO2022227331A1 (en) | Composition for preventing rheumatoid arthritis, preparation method therefor, and application thereof | |
CN103830632A (en) | Chinese traditional medicine preparation for radically treating psoriasis and multiple skin diseases and preparation method and application thereof | |
CN104984297A (en) | Application of pharmaceutical composition in preparation of drugs for treating amenorrhea | |
CN101269170B (en) | Medicament for treating climacteric syndrome and preparation method thereof | |
WO2022227332A1 (en) | Composition for preventing and/or treating rheumatoid arthritis, preparation method therefor, and application thereof | |
CN1263502C (en) | Chinese traditional medicine for treating hypertension | |
CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
CN1814153B (en) | Medicine composition for preventing and treating breast cancer and preparing method | |
CN109248305A (en) | A kind of Chinese medicine composition and preparation method thereof for treating liver fibrosis | |
CN111358906B (en) | Traditional Chinese medicine composition suitable for exogenous diseases | |
CN1935228B (en) | Chinese medicine composition for preventing and treating breast cancer and its preparation method | |
CN102293923A (en) | Application of Tibetan medicinal composition to preparation of medicament for preventing and treating osteoporosis | |
CN105395686A (en) | Folium artemisiae argyi-containing pharmaceutical preparation for treating vaginal bleeding and preparing method thereof | |
CN105477465A (en) | Chinese herb preparation with liver protection function and preparing technology of Chinese herb preparation | |
CN105288538A (en) | Application of medicine composition for preparing medicine for treating amenorrhea | |
CN1144595C (en) | Anticancer capsule | |
CN109364213A (en) | A kind of herbal mixture for treating liver fibrosis | |
CN103405554B (en) | A kind of medicine for the preoperative bowel relieving of abdominal operation | |
CN102038834A (en) | Traditional Chinese medicine preparation for preventing and treating cancers | |
CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
CN113134039A (en) | Traditional Chinese medicine composition, preparation method and application of traditional Chinese medicine composition in preparation of medicine for treating hepatitis B | |
CN1346658A (en) | Chinese medicine for treating hepatofibrosis and hepatocirrhosis | |
CN103405640B (en) | A kind of bowel relieving preparation method of granules preoperative for Induced Labor in Late Pregnancy | |
CN111803598A (en) | Traditional Chinese medicine preparation for eliminating dampness and dredging collaterals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NINGBO YUANZHI BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: YANG XIONGZHI Effective date: 20110719 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315100 ZHEJIANG MEDICAL COLLEGE, NO. 888, EAST SECTION OF YINXIAN AVENUE, YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE TO: 315100 ROOM 402, BUILDING 10, LANE 68, TAIYU ROAD, YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110719 Address after: 315100, room 10, building 68, Lane 402, Tai Mo Road, Ningbo, Zhejiang, Yinzhou District Applicant after: Ningbo Yuanzhi Biotechnology Co., Ltd. Address before: 315100 Zhejiang city of Ningbo province Yinzhou District County Road No. 888 east section of Zhejiang Pharmaceutical College Applicant before: Yang Xiongzhi |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110907 Termination date: 20131205 |